经内镜逆行胰胆管造影胆道金属支架置入治疗不可切除肝外胆道恶性梗阻的效果观察

徐刚

doi:10.3969/j.issn.1001-5256.2018.02.023

经内镜逆行胰胆管造影胆道金属支架置入治疗不可切除肝外胆道恶性梗阻的效果观察

DOI: 10.3969/j.issn.1001-5256.2018.02.023

徐刚

郑州大学第二附属医院消化内科

详细信息

中图分类号: R735
计量
- 文章访问数: 2149
- HTML全文浏览量: 45
- PDF下载量: 405
- 被引次数: 18
出版历程
- 出版日期: 2018-02-20

Clinical effect of biliary metal stent implantation via endoscopic retrograde cholangiopancreatography in treatment of unresectable malignant extrahepatic biliary obstruction

Xu Gang

Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University

摘要

摘要:
目的探讨经内镜逆行胰胆管造影（ERCP）胆道金属支架置入对于肝外胆道恶性梗阻的临床疗效及安全性。方法收集2010年1月-2015年12月郑州大学第二附属医院收治的不可切除性肝外胆道恶性梗阻患者40例。根据手术方法不同分为经皮经肝胆管穿刺引流术（PTCD）组和ERCP组各20例。观察2组患者支架通畅期和生存期、术后临床疗效、术后并发症发生情况、术后住院时间等指标。计量资料组间比较采用t检验;计数资料组间比较采用χ2检验或校正的χ2检验。2组支架通畅期和生存期的比较采用Kaplan-Meier法对数秩检验。结果 ERCP组患者的支架通畅期[（225.6±52.5）d vs（156.3±44.5）d]、生存期[（335.6±42.5）d vs（225.5±42.5）d]较PTCD组均明显延长（t值分别为11.45、10.46,P值均<0.05）。ERCP组患者术后发生腹痛（7例）少于PTCD组（10例）,差异有统计学意义（35.0%vs 50.0%,χ2=9.45,P<0.05）。ERCP组患者术后严重并发症发生率显著低于PTCD组（10.0%vs 30.0%,χ2=7.49,P...
- 胆道疾病 /
- 胰胆管造影术,内窥镜逆行 /
- 治疗结果
Abstract:
Objective To investigate the clinical effect and safety of biliary metal stent implantation via endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of malignant extrahepatic biliary obstruction.Methods A total of 40 patients with unresectable malignant extrahepatic biliary obstruction who were admitted to The Second Affiliated Hospital of Zhengzhou University from January 2010 to December 2015 were enrolled, and according to the surgical method, these patients were divided into percutaneous transhepatic cholangiodrainage (PTCD) group and ERCP group, with 20 patients in each group.The two groups were compared in terms of duration of stent patency, survival time, postoperative clinical outcome, incidence of postoperative complications, and length of postoperative hospital stay.The t-test was used for comparison of continuous data between groups, and the chi-square test or the corrected chi-square test was used for comparison of categorical data between groups.The Kaplan-Meier method was used to compare the differences in duration of stent patency and survival time between the two groups via the log-rank test.Results Compared with the PTCD group, the ERCP group had significant increases in duration of stent patency (225.6 ± 52.5 d vs 156.3 ± 44.5 d, t = 11.45, P < 0.05) and survival time (335.6 ± 42.5 d vs 225.5 ±42.5 d, t = 10.46, P < 0.05) .Seven patients in the ERCP group and 10 in the PTCD group experienced abdominal pain after surgery, and there was a significant difference between these two groups (35.0% vs 50.0%, χ2= 9.45, P < 0.05) .Compared with the PTCD group, the ERCP group had significantly lower incidence rate of severe postoperative complications (10.0% vs 30.0%, χ2= 7.49, P < 0.05) and shorter length of hospital stay (12.4 ± 2.5 d vs 19.8 ± 4.0 d, t = 10.67, P < 0.05) .Conclusion Metal stent implantation via ERCP has a similar clinical effect to PTCD in the treatment of malignant extrahepatic biliary obstruction, while compared with PTCD, ERCP allows for longer duration of stent patency and survival time, fewer complications, and a shorter length of hospital stay.Therefore, ERCP has better clinical effect and safety in patients with malignant extrahepatic biliary obstruction.
- bile duct diseases /
- cholangiopancreatography, endoscopic retrograde /
- treatment outcome

HTML全文

参考文献(15)

[1]CASTRO FA, KOSHIOL J, HSING AW, et al.Biliary tract cancer incidence in the United States-demographic and temporal variations by anatomic site[J].Int J Cancer, 2013, 133 (7) :1664-1671.

[2]BLECHACZ B, KOMUTA M, ROSKAMS T, et al.Clinical diagnosis and staging of cholangiocarcinoma[J].Nat Rev Gastroenterol Hepatol, 2011, 8 (9) :512-522.

[3]DEOLIVEIRA ML, SCHULICK RD, NIMURA Y, et al.New staging system and a registry for perihilar cholangiocarcinoma[J].Hepatology, 2011, 53 (4) :1363-1371.

[4]SIEGEL R, MA J, ZOU Z, et al.Cancer statistics, 2014[J].CA Cancer J Clin, 2014, 64 (1) :9-29.

[5]MOHAMADNEJAD M, DEWITT JM, SHERMAN S, et al.Role of EUS for preoperative evaluation of cholangiocarcinoma:a large single-center experience[J].Gastrointest Endosc, 2011, 73 (1) :71-78.

[6]TELLEZ-AVILA FI, BERNAL-MENDEZ AR, GUERREROVAZQUEZ CG, et al.Diagnostic yield of EUS-guided tissue acquisition as a first-line approach in patients with suspected hilar cholangiocarcinoma[J].Am J Gastroenterol, 2014, 109 (8) :1294-1296.

[7]WEILERT F, BHAT YM, BINMOELLER KF, et al.EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction:results of a prospective, single-blind, comparative study[J].Gastrointest Endosc, 2014, 80 (1) :97-104.

[8]EL CHAFIC AH, DEWITT J, LEBLANC JK, et al.Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients[J].Endoscopy, 2013, 45 (11) :883-889.

[9]TUMMALA P, MUNIGALA S, ELOUBEIDI MA, et al.Patients with obstructive jaundice and biliary stricture±mass lesion on imaging:prevalence of malignancy and potential role of EUS-FNA[J].J Clin Gastroenterol, 2013, 47 (6) :532-537.

[10]KHASHAB MA, FOCKENS P, AL-HADDAD MA.Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos) [J].Gastrointest Endosc, 2012, 76 (5) :1024-1033.

[11]CAPPELL MS, KILLEEN TC, JURY R.Common bile duct carcinoid mimicking the clinical, EUS, and ERCP findings of cholangiocarcinoma:a rare but potentially curable cause of obstructive jaundice[J].Clin Gastroenterol Hepatol, 2011, 9 (11) :e112-e113.

[12]LEVY MJ, HEIMBACH JK, GORES GJ.Endoscopic ultrasound staging of cholangiocarcinoma[J].Curr Opin Gastroenterol, 2012, 28 (3) :244-252.

[13]ANNUNZIATA S, CALDARELLA C, PIZZUTO DA, et al.Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma:a meta-analysis[J].Biomed Res Int, 2014, 2014:247693.

[14]PARK MS, LEE SM.Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer[J].Anticancer Res, 2014, 34 (5) :2551-2554.

[15]ITO Y, KENMOCHI T, EGAWA T, et al.Clinicopathological features of early distal cholangiocarcinoma[J].Hepatogastroenterology, 2013, 60 (124) :673-677.

施引文献

期刊类型引用(17)

1.	郭堑，农村立，韦秋芳. 慢性乙型肝炎肝纤维化患者血清Copeptin和PCT表达水平及其临床价值研究. 现代检验医学杂志. 2023(02): 112-117+189 . 百度学术
2.	李初谊，王俊科，李斌，温雪，魏晓静，于晓辉. 血浆置换对慢加急性肝衰竭辅助治疗的效果评价. 海南医学院学报. 2022(16): 1228-1231 . 百度学术
3.	王鑫，张国民，牛兴杰，李萍，张冰. 外周血CD14~+CD16~+单核细胞亚群在肝衰竭继发感染患者中的检测价值. 中国免疫学杂志. 2020(09): 1124-1127+1130 . 百度学术
4.	姜曼蕾，许飞，胡江玲，罗嘉裕，罗方云. IL-6、CRP、PCT和内毒素预判肝衰竭合并细菌感染风险中的临床价值. 中华医院感染学杂志. 2020(20): 3062-3065 . 百度学术
5.	张国民，王鑫，韩智炜，牛兴杰，刘志慧，崔凤梅. 降钙素原、白细胞介素6、sCD14、CD64检测在肝功能衰竭患者诊治中的临床研究. 中国现代医学杂志. 2019(03): 47-51 . 百度学术
6.	江艳霞，骆小燕，骆旭航，龚安安，孙爱华. 血清降钙素原在胆管炎危重度早期评估中的价值研究. 中国卫生检验杂志. 2019(04): 462-463+468 . 百度学术
7.	张国民，韩智炜，牛兴杰，刘志慧，王鑫. IL-6、CD14、CD64检测在感染所致肝衰竭患者中意义. 现代医学. 2019(02): 137-140 . 百度学术
8.	黄波，张炜. 喜炎平注射液联合还原型谷胱甘肽治疗重症烧伤后急性肝功能损伤临床研究. 创伤与急危重病医学. 2019(03): 156-159 . 百度学术
9.	杨丽霞，张伦理，赖玲玲，方铭. 腹水中肝素结合蛋白及降钙素原对肝硬化腹水伴自发性细菌性腹膜炎的诊断价值. 临床肝胆病杂志. 2019(06): 1266-1269 . 本站查看
10.	李薇，任小丹，何谦，周荣幸. 血清降钙素原检测对胆道梗阻合并感染者的预测价值. 中华实验和临床感染病杂志(电子版). 2019(03): 245-249 . 百度学术
11.	张国民，韩智炜，牛兴杰，刘志慧，崔凤梅，王鑫. PCT、IL-6、CD14、CD64及TNF-α表达对肝衰竭合并医院感染患者预后的影响. 中华医院感染学杂志. 2019(16): 2450-2453 . 百度学术
12.	王鑫，张国民，牛兴杰，李萍，张冰. 肝衰竭继发感染患者外周血Toll样受体4及降钙素原、C反应蛋白变化情况分析. 现代消化及介入诊疗. 2019(10): 1084-1087+1094 . 百度学术
13.	石春霞，陈倩，王瑶，焦方舟，龚作炯. 肝功能衰竭并感染患者血清正五聚蛋白3和肝素结合蛋白及降钙素原水平变化. 中华实用诊断与治疗杂志. 2019(12): 1188-1190 . 百度学术
14.	顾静，王艳，陈丽，徐英，甘建和. HBV相关慢加急性肝衰竭患者血清IL-32和IL-10水平变化及意义. 临床肝胆病杂志. 2018(04): 801-805 . 本站查看
15.	王小芳，奉万盛，周红翠，邱咏佳. 血清降钙素原、白细胞计数、C-反应蛋白与细菌血培养联合检测在感染患者中的应用价值. 中国医药导报. 2018(19): 75-78 . 百度学术
16.	沈素晶，邓超，李霭文，谭俊青. 不同化学发光检测系统测定PCT结果的相关性分析. 实验与检验医学. 2018(06): 873-875+891 . 百度学术
17.	詹金美，林欢，孙家敏. 定量检测血清降钙素原在诊断肝衰竭患者腹腔感染细菌类型中的价值. 中外医疗. 2017(28): 34-36 . 百度学术